Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 26, 2015
- Accepted July 22, 2015
- Published online August 24, 2015.
Article Versions
- Earlier version (July 22, 2015 - 08:49).
- Earlier version (July 22, 2015 - 10:22).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Chungang Gu,
- Richard J. Lewis,
- Andrew S. Wells,
- Per H. Svensson,
- Vinayak P. Hosagrahara,
- Eskil Johnsson, and
- Gösta Hallström
- AstraZeneca, R&D Boston, Waltham, Massachusetts (C.G., V.P.H.); AstraZeneca, R&D Mölndal, Mölndal, Sweden (R.J.L., E.J.); AstraZeneca, R&D Charnwood, Loughborough, United Kingdom (R.J.L., A.S.W.); AstraZeneca, R&D Södertälje, Södertälje, Sweden (P.H.S); AstraZeneca, R&D Wilmington, Wilmington, Delaware (C.G.); AstraZeneca, R&D Lund, Lund, Sweden (E.J., G.H.); SP Process Development, Södertälje, Sweden (P.H.S.); and Applied Physical Chemistry, Royal Institute of Technology, Stockholm, Sweden (P.H.S.)
- Address correspondence to:
Dr. Chungang Gu, AstraZeneca R&D Boston, Oncology DMPK, 35 Gatehouse Drive, Waltham, MA 02451. E-mail: Chungang.gu{at}astrazeneca.com